$晶泰控股(0222_老虎社区_美港股上老虎

$晶泰控股(02228)$ 晶泰药物发现解决方案实现收入人民币5.38亿元，涵盖小分子药物、生物大分子及新型多肽等研发管线，与全球领先制药企业及前沿生物科技公司建立多种合作模式。

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":556288959338368,"tweetId":"556288959338368","gmtCreate":1776841311093,"gmtModify":1776842045980,"author":{"id":4108172460082090,"idStr":"4108172460082090","authorId":4108172460082090,"authorIdStr":"4108172460082090","name":"Gudrun","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"wearingBadges":[],"fanSize":22,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"title":"","html":"<html><head></head><body><p><a href=\"https://laohu8.com/S/02228\">$晶泰控股(02228)$ </a> 晶泰药物发现解决方案实现收入人民币5.38亿元，涵盖小分子药物、生物大分子及新型多肽等研发管线，与全球领先制药企业及前沿生物科技公司建立多种合作模式。</p></body></html>","htmlText":"<html><head></head><body><p><a href=\"https://laohu8.com/S/02228\">$晶泰控股(02228)$ </a> 晶泰药物发现解决方案实现收入人民币5.38亿元，涵盖小分子药物、生物大分子及新型多肽等研发管线，与全球领先制药企业及前沿生物科技公司建立多种合作模式。</p></body></html>","text":"$晶泰控股(02228)$ 晶泰药物发现解决方案实现收入人民币5.38亿元，涵盖小分子药物、生物大分子及新型多肽等研发管线，与全球领先制药企业及前沿生物科技公司建立多种合作模式。","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/556288959338368","repostId":0,"isVote":1,"tweetType":1,"viewCount":755,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["02228"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":159,"optionInvolvedFlag":false,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/556288959338368"}